IL6 and systemic lupus erythematosus: In MRL/lpr lupus-prone mice, another derivative, SM934, increased survival, decreased IL-6, IL-10, IL-12, and activated B cells and plasma cells [97], and lowered proteinuria, renal injury, BUN, and serum anti-dsDNA antibodies [96].